手术机器人市场规模：按组件、按应用、按地区、范围和预测

手术机器人市场规模及预测

2024年手术机器人市场规模为100.3亿美元，预计2024年至2031年复合年增长率为17.97%，到2031年将达到335.5亿美元。手术机器人是一种微创手术，利用电脑控制的机器人系统在手术过程中协助外科医生。机器人手术是使用自动化技术进行的手术。机器人辅助手术旨在解决现有微创手术的缺点，提升医师进行传统开放式手术的能力。在机器人辅助的微创手术中，医生使用两种方法之一来控制它们，而不是物理操作工具。这些方法包括直接遥控方法和电脑控制方法。远端操纵器是一种远端操纵器，可让外科医生在手术过程中执行所需的精确运动。然后，机械手臂使用末端执行器和仪器来模仿这些运动并执行外科手术。在电脑控制系统中，外科医生使用电脑指令来驱动机械手臂或末端执行器，但这些系统可能仍有远端操纵器用于输入。

电脑控制的优点之一是医生不需要亲自在场，可能允许远端手术。储存设备对于确保无缝机器人辅助手术至关重要。

根据患者的医疗记录，这些储存解决方案具有多种用途，包括储存用于校准调整的特定资讯、检测储存决策系统中的差异以及监控资料寿命。

作为参考资料

世界手术机器人市场动态

塑造全球手术机器人市场的关键市场动态

主要市场驱动因子

微创方法：

机器人辅助手术 (RAS) 提供了传统开放性手术的微创替代方案。这种方法为患者带来了多种好处，包括切口更小、失血更少、恢復时间更快、术后疼痛更少。较小的切口还可以降低感染风险并最大程度地减少疤痕，从而改善患者的整体体验和结果。

提高精度和控制：

RAS 增强了手术器械的精确度和控制。机械手臂可以比人手更精确地进行运动，从而最大限度地减少手部颤抖并提高手术精度。这种增强的控制对于复杂而精细的手术特别有益，因为即使是最轻微的错误也可能造成严重的后果。外科医生可以以更高的精度进行复杂的手术，从而获得更好的临床结果。

改进的视觉化：

RAS系统配备了高清3D摄像头，可以放大手术部位。这种先进的可视化使外科医生能够详细瞭解解剖结构，从而有助于在手术过程中做出明智的决策。提高组织和器官的可视性可以更轻鬆地识别和保存关键结构，从而减少併发症的机会。

对微创手术的需求不断增加：

随着越来越多的患者更喜欢微创手术而不是传统的开放性手术，对微创手术的需求正在增加。这一趋势是由微创手术的优点所推动的，包括更快的恢復时间、减轻疼痛以及更快地恢復日常活动。因此，对能够更准确、更有效地执行这些微创手术的手术机器人的需求不断增长。

人口老化：

世界人口老化正在增加对复杂外科手术的需求。老年患者通常有合併症，传统的开放性手术有风险。 RAS 减少了与手术相关的身体创伤，使其成为这些患者的更安全的选择。机器人手术的精确性和微创性使其特别适合老年患者，他们的康復速度更快，併发症更少。

技术进步：

机器人技术的不断进步正在提高手术机器人的功能和易用性。现代手术机器人正变得更加复杂、更容易使用且用途更加广泛。这些进步正在扩大机器人手术在各种外科专业的应用范围，包括心臟科、泌尿科、妇科和骨科。提高机器人灵活性、触觉回馈和人工智慧整合等创新进一步突破了机器人手术所能实现的界限。

政府措施：

在一些国家，政府措施和支持性报销政策正在促进手术机器人在医疗机构中的实施。这些努力通常包括资助机器人手术计画、培训医疗专业人员以及激励医院投资先进手术技术。支持政策将大大加速将机器人系统引入临床实践，使这些先进的手术更容易为患者所接受。

医疗保健效率：

手术机器人有潜力透过减少手术室时间和增强手术工作流程来提高医疗保健效率。 RAS 提供的精确度和控制可以实现更快、更有效率的手术，同时减少併发症。这些效率转化为更低的整体医疗成本，因为更短的手术时间和更快的恢復减少了住院时间和相关成本。此外，外科手术量的增加使医疗机构能够更有效地管理患者数量并改善获得手术护理的机会。

主要问题

成本高：

手术机器人系统的高成本是其广泛使用的主要障碍。这些先进的机器每台价值数百万美元，这对医院和外科中心来说是一项很高的初始投资。在预算有限的环境中，尤其是小型或农村医疗机构，可能很难分配购买和维护这些系统所需的资金。此外，除了初始购买成本外，维护、维修和更新成本也增加了财务资源的压力。

限量兑换：

机器人手术的报销政策可能不一致，并且因国家和医疗保健系统而异。在许多情况下，保险或政府报销不能完全涵盖与机器人手术相关的额外费用。这些经济差异可能会使机器人手术对医院来说不再有吸引力。如果报销不能证明所产生的高成本是合理的，医院可能不愿意采用这些技术。

陡峭的学习曲线：

手术机器人的有效使用需要对外科医生和手术人员进行广泛的培训。这种训练既耗时又昂贵，因为它不仅涉及学习如何操作机器人系统，还涉及适应新的手术技术和方案。陡峭的学习曲线可能会延迟机器人手术计划的采用，因为医院在提供这些先进的手术之前必须在教育和培训方面投入大量资源。增加负担的是需要持续培训以跟上技术进步。

缺乏长期数据：

儘管机器人手术的短期益处已有充分记录，但仍缺乏将患者结果与传统手术方法进行比较的全面长期数据。这种数据差距可能会导致外科医生和患者犹豫不决，因为机器人辅助手术的长期疗效和安全性尚不清楚。纵向研究对于更清楚瞭解 RAS 的好处和潜在风险至关重要，这将有助于就 RAS 实施做出明智的决策。

使用有限：

手术机器人并不适用于所有手术。这项技术仍处于起步阶段，可能不适合传统技术更有效或更具成本效益的手术。对于某些手术，机器人方法可能无法提供比传统方法显着的优势，外科医生可能更喜欢传统技术。此外，用于特定外科手术的机器人系统的开发目前正在进行中，并且一些应用尚未针对临床使用进行完全优化或验证。

主要趋势

人工智慧与机器学习的兴起：

人工智慧 (AI) 和机器学习 (ML) 演算法的整合正在彻底改变机器人辅助手术。人工智慧可以协助外科医生在手术过程中做出决策，分析患者数据以预测潜在的併发症，并自动执行重复性任务。此外，机器学习可以根据每位患者的解剖结构和病史定製手术程序，从而提高准确性和治疗结果。

用途扩充：

手术机器人目前的应用范围超出了传统的泌尿科和妇科领域。在一般外科、心臟外科、头颈外科等领域不断出现新的用途。随着机器人技术的进步，适合机器人支援的手术范围不断扩大，预计将在多种医疗领域中采用。

注重成本效益：

虽然负担能力仍然是一个关键问题，但人们越来越重视成本控制解决方案。在开发低成本机器人系统、引入创新融资模式以及简化手术工作流程以优化手术室时间方面正在取得进展。这些措施旨在使机器人辅助手术对于医疗保健提供者来说更容易获得且经济上可行。

远距呈现与远距手术：

技术的进步为远端手术铺平了道路，使外科医生能够从远端位置操作机器人。这种能力有可能改善服务不足地区和紧急情况下获得专业外科护理的机会。远距呈现手术可能会彻底改变外科护理的提供方式，使更多的人能够接受专门的手术。

增强的触觉回馈：

目前的机器人系统已经改善了触觉回馈，使外科医生能够在手术过程中感受到组织压力和阻力。增强的触觉回馈提供了更自然、直观的体验，更接近传统开放性手术的感觉。这项进步使外科医生能够进行更精确、更自信的手术。

协作机器人的出现：

新一代协作手术机器人正在出现。这些机器人被设计为充当外科医生的助手，而不是替代者，执行诸如握住手术器械和缩回组织等任务。这种协作方法可以提高手术效率、减少外科医生疲劳并改善整体手术结果。

日益关注网路安全：

随着手术机器人越来越多地与复杂的软体和数据系统集成，网路安全问题变得至关重要。该行业致力于开发强大的网路安全措施，以保护患者资料并确保机器人系统的安全运作。拥有强大的网路安全协议对于保持机器人辅助手术的可靠和安全至关重要。

目录

第1章全球手术机器人市场：简介

• 市场概览
• 调查范围
• 先决条件

第 2 章执行摘要

第3章验证市场研究研究方法

• 资料探勘
• 验证
• 资料来源列表

第4章全球手术机器人市场展望

• 摘要
• 市场动态
  • 促进因素
  • 阻碍因素
  • 机会

第5章全球手术机器人市场：依组成部分

• 摘要
• 元件
  • 机器人系统
  • 设备及配件

第6章全球手术机器人市场：依应用划分

• 摘要
  • 骨科
  • 神经外科
  • 一般外科
  • 妇科手术
  • 泌尿科
  • 其他

第7章全球手术机器人市场：依地区划分

• 摘要
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地区
• 中东/非洲
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 其他中东和非洲地区

第8章全球手术机器人市场：竞争格局

• 摘要
• 企业市场排名
  • Intuitive Surgical, Inc. (US)
  • Stryker Corporation (US)
  • Mazor Robotics (Israel)
  • Hansen Medical (US)
  • TransEnterix, Inc. (US)
  • Medtech SA (France)
  • Merck Co. & Inc (US)
  • Verb Surgical Inc. (US)
  • Smith & Nephew (UK)
  • Renishaw PLC (UK)
  • Medrobotics Corporation (US)
• 主要发展策略

第 9 章附录

• 相关报告

Surgical Robotics Market Size And Forecast

Surgical Robotics Market size was valued at USD 10.03 Billion in 2024 and is projected to reach USD 33.55 Billion by 2031, growing at a CAGR of 17.97% from 2024 to 2031. Surgical robotics is a type of minimally invasive surgery that utilizes computer-controlled robotic systems to assist surgeons during procedures. Robotic surgeries are procedures carried out employing automated technology. Robotically-assisted surgery was created to solve shortcomings in existing minimally invasive surgical procedures and to improve the ability of doctors doing traditional open surgeries. Instead of physically handling tools in robotically-assisted minimally invasive surgery, physicians use one of two approaches to control them. These methods include using a direct telemanipulator and computer control. A telemanipulator is a remote manipulator that allows surgeons to perform the precise movements required during surgery. Robotic arms then imitate these movements with end-effectors and equipment to carry out the surgical procedure. In computer-controlled systems, surgeons use computer orders to drive robotic arms and end-effectors, while these systems may still have telemanipulators for input.

One advantage of computerized control is that doctors are not required to be physically present, which could enable remote surgery. Memory devices are critical for guaranteeing seamless robot-assisted operations.

These storage solutions serve a variety of purposes depending on patients' medical records, including storing specific information for calibration adjustments, detecting differences in the storage determination system, and monitoring data longevity, among other things.

To Learn More:

Global Surgical Robotics Market Dynamics

The key market dynamics that are shaping the global surgical robotics market include:

Key Market Drivers

Minimally Invasive Approach:

Robotic-assisted surgery (RAS) offers a minimally invasive alternative to traditional open surgery. This approach results in several patient benefits, including smaller incisions, reduced blood loss, quicker recovery times, and less postoperative pain. The smaller incisions also lower the risk of infection and lead to minimal scarring, improving the overall patient experience and outcomes.

Enhanced Precision and Control:

RAS is the enhanced precision and control over surgical instruments. Robotic arms can execute movements with greater accuracy than human hands, minimizing hand tremors and enhancing surgical precision. This increased control is especially beneficial for complex and delicate procedures, where even minor errors can have significant consequences. Surgeons can perform intricate operations with improved accuracy, leading to better clinical outcomes.

Improved Visualization:

RAS systems are equipped with high-definition 3D cameras that provide magnified views of the surgical site. This advanced visualization allows surgeons to see anatomical structures in exceptional detail, facilitating more informed decision-making during surgery. The enhanced visibility of tissues and organs helps in identifying and preserving vital structures, reducing the likelihood of complications.

Growing Demand for Minimally Invasive Procedures:

The demand for minimally invasive procedures is rising as patients increasingly prefer these options over traditional open surgeries. The benefits of minimally invasive techniques, such as shorter recovery times, reduced pain, and quicker return to daily activities, are driving this trend. Consequently, there is a growing demand for surgical robots, which enable these less invasive procedures to be performed with greater precision and efficacy.

Aging Population:

The global population is aging, resulting in a higher demand for complex surgical procedures. Elderly patients often have comorbidities that make traditional open surgery riskier. RAS offers a safer alternative for these patients, as it reduces the physical trauma associated with surgery. The precision and minimally invasive nature of robotic surgery make it particularly suitable for elderly patients, who may experience faster recovery and fewer complications.

Technological Advancements:

Continuous advancements in robotics technology are enhancing the capabilities and usability of surgical robots. Modern surgical robots are becoming more sophisticated, user-friendly, and versatile. These advancements are expanding the range of applications for robotic surgery across various surgical specialties, including cardiology, urology, gynecology, and orthopedics. Innovations such as improved robotic dexterity, haptic feedback, and AI integration are further pushing the boundaries of what can be achieved with robotic surgery.

Government Initiatives:

In several countries, government initiatives and supportive reimbursement policies are promoting the adoption of surgical robots in healthcare facilities. These initiatives often include funding for robotic surgery programs, training for healthcare professionals, and incentives for hospitals to invest in advanced surgical technologies. Supportive policies can significantly accelerate the integration of robotic systems into clinical practice, making these advanced procedures more accessible to patients.

Increased Focus on Healthcare Efficiency:

Surgical robots have the potential to improve healthcare efficiency by reducing the time spent in the operating room and enhancing surgical workflows. The precision and control offered by RAS can lead to faster, more efficient surgeries with fewer complications. This efficiency can translate to lower overall healthcare costs, as shorter surgeries and quicker recoveries reduce hospital stays and associated expenses. Additionally, the increased throughput in surgical departments can help healthcare facilities manage patient loads more effectively, improving access to surgical care.

Key Challenges

High Cost:

The high cost of surgical robotic systems represents a significant barrier to widespread adoption. These advanced machines can cost millions of dollars each, making the initial investment steep for hospitals and surgical centers. Budget-constrained environments, particularly in smaller or rural healthcare facilities, may find it challenging to allocate the necessary funds for purchasing and maintaining these systems. Additionally, the cost extends beyond the initial purchase, encompassing maintenance, repairs, and updates, further straining financial resources.

Limited Reimbursement:

Reimbursement policies for robotic surgery procedures can be inconsistent, varying widely across countries and even within different healthcare systems. In many cases, insurance and government reimbursements may not fully cover the additional costs associated with robotic surgery. This financial gap can make robotic surgery a less attractive option for hospitals, as they might not recoup their investments adequately. Hospitals may hesitate to adopt these technologies if the reimbursement rates do not justify the higher expenses incurred.

Steep Learning Curve:

Effectively utilizing surgical robots requires extensive training for surgeons and surgical staff. This training is both time-consuming and costly, as it involves not only learning how to operate the robotic systems but also adapting to new surgical techniques and protocols. The steep learning curve can delay the implementation of robotic surgery programs, as hospitals need to invest significant resources in education and training before, they can offer these advanced procedures. The need for ongoing training to keep up with technological advancements adds to the burden.

Lack of Long-Term Data:

While the short-term benefits of robotic surgery are well-documented, there is still a lack of comprehensive long-term data comparing patient outcomes to those of traditional surgical methods. This gap in data can create hesitation among surgeons and patients, as they might be uncertain about the long-term efficacy and safety of robotic-assisted procedures. Long-term studies are crucial to provide a clearer understanding of the benefits and potential risks associated with RAS, which can help in making informed decisions about its adoption.

Limited Applications:

Surgical robots are not universally applicable to all types of surgery. The technology is still evolving and may not be suitable for certain procedures where traditional techniques are more efficient or cost-effective. For some operations, the robotic approach may not offer significant advantages over conventional methods, leading surgeons to prefer traditional techniques. Additionally, the development of robotic systems for specific surgical procedures is ongoing, and some applications are not yet fully optimized or validated for clinical use.

Key Trends

Rise of AI and Machine Learning:

The integration of artificial intelligence (AI) and machine learning (ML) algorithms is revolutionizing robotic-assisted surgery. AI can aid surgeons in decision-making during procedures, analyze patient data to predict potential complications and automate repetitive tasks. Additionally, ML can personalize surgical procedures by tailoring them to the individual patient's anatomy and medical history, enhancing precision and outcomes.

Expanding Applications:

Surgical robots are now being utilized beyond their traditional domains of urology and gynecology. New applications are emerging in general surgery, cardiac surgery, and head and neck surgery. As robotic technology continues to advance, the range of procedures suitable for robotic assistance is expanding, promising broader adoption across various medical specialties.

Focus on Cost-Effectiveness:

Affordability remains a significant challenge, but there is a growing emphasis on cost-containment solutions. Efforts are being made to develop more affordable robotic systems, introduce innovative financing models, and streamline surgical workflows to optimize operating room time. These measures aim to make robotic-assisted surgery more accessible and economically viable for healthcare providers.

Telepresence and Remote Surgery:

Technological advancements are paving the way for telepresence surgery, enabling surgeons to operate robots remotely from distant locations. This capability has the potential to improve access to specialized surgical care in underserved areas and during emergencies. Telepresence surgery could revolutionize how surgical care is delivered, making expert procedures available to a broader population.

Enhanced Haptic Feedback:

Current robotic systems are improving haptic feedback, allowing surgeons to feel the pressure and resistance of tissues during surgery. Enhanced haptic feedback provides a more natural and intuitive experience, closely mimicking the sensations of traditional open surgery. This advancement helps surgeons perform procedures with greater accuracy and confidence.

Emergence of Collaborative Robots:

A new generation of collaborative surgical robots is emerging. These robots are designed to act as assistants rather than replacements for surgeons, performing tasks such as holding surgical instruments or retracting tissues. This collaborative approach can enhance surgical efficiency, reduce surgeon fatigue, and improve overall procedural outcomes.

Growing Focus on Cybersecurity:

As surgical robots become increasingly integrated with complex software and data systems, cybersecurity concerns are becoming paramount. The industry is focusing on developing robust cybersecurity measures to protect patient data and ensure the safe operation of robotic systems. Implementing strong cybersecurity protocols is essential to maintaining trust and safety in robotic-assisted surgery.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Surgical Robotics Market Regional Analysis

Here is a more detailed regional analysis of the global surgical robotics market:

North America

North America is substantially dominating the global surgical robotics market owing to the increasing number of surgical procedures in North America is a major driver of market expansion.

As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients.

North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

These technical advancements make robotic-assisted procedures more accessible and effective, accelerating their acceptance across a variety of medical disciplines.

The North American region has a considerable influence on the worldwide surgical robot industry. The market is being driven by a high degree of knowledge about the benefits of robotic-assisted operations among healthcare professionals and patients alike.

Educational campaigns and professional training programs are improving surgeons' competency in using these advanced technologies, consequently expanding their acceptance and use.

Higher surgical robot adoption rates in North America are also driving market expansion. Robotic systems are progressively being integrated into operating rooms by hospitals and surgical centers because of their advantages in terms of precision, decreased recovery periods, and improved patient outcomes.

Healthcare providers' willingness to invest in these technologies, despite their high initial costs, demonstrates the perceived value and long-term advantages of robotically assisted surgery.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the global surgical robotics market owing to the region's tremendous economic growth, which has a substantial impact on the healthcare sector.

This economic boom is driving up investments in healthcare infrastructure and the deployment of modern medical technologies such as surgical robots. The region's economic vigor provides a perfect setting for the implementation of cutting-edge surgical treatments.

Increasing geriatric population in the APAC area. Mirroring global trends, the demographic shift toward an older population is increasing the incidence of chronic diseases and, as a result, the demand for complex surgical treatments.

Surgical robots, noted for their minimally invasive nature, are becoming increasingly popular among patients and healthcare practitioners due to their ability to shorten recovery periods and enhance surgical results.

They also play an important role in the adoption of surgical robots in the Asia-Pacific area. Several governments are actively promoting the development and implementation of these technologies through generous reimbursement policies and financing programs. Such initiatives boost market expansion by making modern surgical procedures more accessible to healthcare facilities.

The APAC region bears a tremendous burden of chronic diseases, such as cancer and cardiovascular disease. These disorders necessitate complicated surgical treatments, and surgical robots provide minimally invasive alternatives that can improve patient outcomes while lowering total healthcare expenditures. The rising illness burden is pushing the demand for better surgical technology.

Additionally, there is a rising emphasis on minimally invasive surgery in the APAC area. Patients and healthcare providers are increasingly preferring these procedures to their associated benefits, such as speedier recovery and less pain.

Surgical robots are well-suited to address this demand, as they offer precise and efficient solutions for a wide range of surgical needs. This propensity for fewer intrusive treatments is helping surgical robots gain traction in the market.

Global Surgical Robotics Market: Segmentation Analysis

The Global Surgical Robotics Market is segmented based on Component, Application, And Geography.

Surgical Robotics Market, By Components

• Robot Systems
• Instruments and Accessories

Based on the Component, the Surgical Robotics Market is bifurcated into Robots System and Instruments and Accessories. The robotic systems segment is showing significant growth in the Global Surgical Robotics Market owing to the advanced features including 3D-HD imaging and a wide range of surgical equipment required for surgical procedures. These technologies not only help surgeons spot problems, but they also make it easier to perform difficult surgical procedures thanks to their improved visibility and magnification capabilities, fueling market growth. Furthermore, the operation of robotic systems significantly reduces the risk of errors and post-operative complications, assuring the continuous growth and implementation of robotic technology in surgical settings.

Surgical Robotics Market, By Application

• Orthopedic Surgery
• Neurosurgery
• General Surgery
• Gynaecology Surgery
• Urological Surgery

Based on the Application, the Surgical Robotics Market is bifurcated into Orthopedic Surgery, Neurosurgery, General Surgery, Gynaecology Surgery, and Urological Surgery. The gynecology market is expanding rapidly due to the increased use of robotically assisted surgery for a variety of gynecological procedures. These include benign hysterectomy, myomectomy, and gynecologic cancer operations, among others. The FDA's acceptance of the da Vinci surgical system for gynecologic surgery has greatly increased the number of robotic surgeries performed in this discipline. Furthermore, the increasing frequency of C-section procedures and the growing patient desire for minimally invasive robotic-assisted surgeries are likely to fuel industry growth.

Surgical Robotics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Surgical Robotics Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is substantially dominating the Global Surgical Robotics Market owing to the increasing number of surgical procedures in North America is a major driver of market expansion. As the population ages and chronic disorders requiring surgical intervention become more common, the demand for sophisticated surgical solutions grows. Robotic-assisted operations, which are noted for their precision and low invasive nature, are increasingly popular among both surgeons and patients. North America is a hotbed of technological innovation, and surgical robotics is no exception. Continuous improvements in robotic technologies, including as improved robotic arms, advanced imaging systems, and sophisticated AI-driven capabilities, improve the efficacy and safety of surgical procedures.

Key Players

• The "Global Surgical Robots Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Intuitive Surgical, Inc., Stryker Corporation, Mazor Robotics, Hansen Medical, TransEnterix, Inc., Medtech SA, Merck Co. & Inc., Verb Surgical, Inc., Smith & Nephew, Renishaw PLC, Medrobotics Corporation.
• The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Surgical Robots Market Recent Developments
• In August 2021, Medtronic, a global leader in medical technology, is expected to reach some regulatory hurdles for its soft-tissue robot. CEO Geoff Martha revealed in a recent earnings call that the company is on its approach to submitting for a CE mark and is expecting a new device rejection from the FDA for the highly anticipated soft-tissue surgical robot.
• In February 2022, Kinova announced the signing of a five-year contract agreement with Auris Health. According to the agreement, the firm will work with Auris to develop its Monarch robotic-assisted surgery system.
• In November 2021, Merck & Co., Inc. announced that it is collaborating with Synthekine Inc. to use the latter's unique surrogate cytokine agonist participate in the discovery, development, and marketing of new cytokine therapies. Under the terms of the agreement, Synthekine will conduct initial research, while Merck will have exclusive rights to develop, manufacture, and commercialize surrogate cytokine agonists for up to two cytokines.

TABLE OF CONTENTS

1 INTRODUCTION OF THE GLOBAL SURGICAL ROBOTS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 List of Data Sources

4 GLOBAL SURGICAL ROBOTS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities

5 GLOBAL SURGICAL ROBOTS MARKET BY COMPONENTS

• 5.1 Overview
• 5.2 Components
  • 5.2.1 Robot systems
  • 5.2.2 Instruments and accessories

6 GLOBAL SURGICAL ROBOTS MARKET BY APPLICATION

• 6.1 OVERVIEW
  • 6.1.1 Orthopaedic surgery
  • 6.1.2 Neurosurgery
  • 6.1.3 General surgery
  • 6.1.4 Gynaecology surgery
  • 6.1.5 Urologic Surgery
  • 6.1.6 Others

7 GLOBAL SURGICAL ROBOTS MARKET BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Argentina
  • 7.5.3 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 South Africa
  • 7.6.4 Rest of Middle East and Africa

8 GLOBAL SURGICAL ROBOTS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
  • 8.2.1 Intuitive Surgical, Inc. (US),
  • 8.2.2 Stryker Corporation (US),
  • 8.2.3 Mazor Robotics (Israel),
  • 8.2.4 Hansen Medical (US),
  • 8.2.5 TransEnterix, Inc. (US),
  • 8.2.6 Medtech SA (France),
  • 8.2.7 Merck Co. & Inc (US),
  • 8.2.8 Verb Surgical Inc. (US),
  • 8.2.9 Smith & Nephew (UK),
  • 8.2.10 Renishaw PLC (UK),
  • 8.2.11 Medrobotics Corporation (US)
• 8.3 Key Development Strategies

9 Appendix

• 9.1.1 Related Reports